Seeking Alpha

  InterMune, Inc. - NASDAQ

11/27/2014, 7:22 PM ET
  • Robert Weinstein | Send Message 4 Mar 2011

    shorting $ITMN $43.19 and higher for next 20 mins with a profit target of 45 cents
      ITMN vs. ETF Alternatives
      Company Description
      InterMune, Inc., is a biotechnology company. It is engaged in the research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States